Search research articles
Contact Us
Filters
Showing results (1-10 of 72) with videos related to
Page
of 8
Sort By:
Journal of Blood Medicine
|
January 28, 2012
The role of ofatumumab in the treatment of chronic lymphocytic leukemia resistant to previous therapies
Jorge Castillo, Kimberly Perez
Current Opinion in Molecular Therapeutics
|
March 31, 2009
Veltuzumab, an anti-CD20 mAb for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia and immune thrombocytopenic purpura
Cannon Milani, Jorge Castillo
FEBS Letters
|
May 6, 2016
The developmental and pathogenic roles of BAF57, a special subunit of the BAF chromatin-remodeling complex
Hilda Lomelí, Jorge Castillo-Robles
Experimental Hematology
|
June 21, 2008
Newer monoclonal antibodies for hematological malignancies
Jorge Castillo, Eric Winer, Peter Quesenberry
Diabetes Care
|
November 27, 2008
Diabetes and risk of Non-Hodgkin's lymphoma: a meta-analysis of observational studies
Joanna Mitri, Jorge Castillo, Anastassios G Pittas
Expert Opinion on Investigational Drugs
|
April 2, 2009
Ofatumumab, a second-generation anti-CD20 monoclonal antibody, for the treatment of lymphoproliferative and autoimmune disorders
Jorge Castillo, Cannon Milani, Daniel Mendez-Allwood
American Journal of Hematology
|
August 30, 2008
HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases
Jorge Castillo, Liron Pantanowitz, Bruce J Dezube
Zebrafish
|
August 14, 2019
Protein Purification and Western Blot Detection from Single Zebrafish Embryo
Denhi Schnabel, Jorge Castillo-Robles, Hilda Lomeli
Social Studies of Science
|
November 18, 2022
Biopolitics and speculative objects in Chilean health projects
Jorge Castillo-Sepúlveda, Francisco Tirado, Ana Gálvez
American Journal of Hematology
|
October 22, 2009
Management of hematological malignancies during pregnancy
Tina Rizack, Anthony Mega, Robert Legare, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 72) with videos related to
Sort By:
Page
of 8
Journal of Blood Medicine
|
January 28, 2012
The role of ofatumumab in the treatment of chronic lymphocytic leukemia resistant to previous therapies
Jorge Castillo, Kimberly Perez
Current Opinion in Molecular Therapeutics
|
March 31, 2009
Veltuzumab, an anti-CD20 mAb for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia and immune thrombocytopenic purpura
Cannon Milani, Jorge Castillo
FEBS Letters
|
May 6, 2016
The developmental and pathogenic roles of BAF57, a special subunit of the BAF chromatin-remodeling complex
Hilda Lomelí, Jorge Castillo-Robles
Experimental Hematology
|
June 21, 2008
Newer monoclonal antibodies for hematological malignancies
Jorge Castillo, Eric Winer, Peter Quesenberry
Diabetes Care
|
November 27, 2008
Diabetes and risk of Non-Hodgkin's lymphoma: a meta-analysis of observational studies
Joanna Mitri, Jorge Castillo, Anastassios G Pittas
Expert Opinion on Investigational Drugs
|
April 2, 2009
Ofatumumab, a second-generation anti-CD20 monoclonal antibody, for the treatment of lymphoproliferative and autoimmune disorders
Jorge Castillo, Cannon Milani, Daniel Mendez-Allwood
American Journal of Hematology
|
August 30, 2008
HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases
Jorge Castillo, Liron Pantanowitz, Bruce J Dezube
Zebrafish
|
August 14, 2019
Protein Purification and Western Blot Detection from Single Zebrafish Embryo
Denhi Schnabel, Jorge Castillo-Robles, Hilda Lomeli
Social Studies of Science
|
November 18, 2022
Biopolitics and speculative objects in Chilean health projects
Jorge Castillo-Sepúlveda, Francisco Tirado, Ana Gálvez
American Journal of Hematology
|
October 22, 2009
Management of hematological malignancies during pregnancy
Tina Rizack, Anthony Mega, Robert Legare, et al.
Page
of 8